Literature DB >> 19776760

PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy.

C G Molteni, G Te Kronnie, S Bicciato, T Villa, M Tartaglia, G Basso, A Biondi, G Cazzaniga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19776760     DOI： 10.1038/leu.2009.200

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.

Authors:  Heather Mason-Suares; Diana Toledo; Jean Gekas; Katherine A Lafferty; Naomi Meeks; M Cristina Pacheco; David Sharpe; Thomas E Mullen; Matthew S Lebo
Journal:  Eur J Hum Genet       Date:  2017-01-18       Impact factor: 4.246

2.  PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.

Authors:  Jianqiao Xiao; Seung-Tae Lee; Yuanyuan Xiao; Xiaomei Ma; E Andres Houseman; Ling-I Hsu; Ritu Roy; Margaret Wrensch; Adam J de Smith; Anand Chokkalingam; Patricia Buffler; John K Wiencke; Joseph L Wiemels
Journal:  Int J Cancer       Date:  2014-02-19       Impact factor: 7.396

Review 3.  A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia.

Authors:  Daniela Senft; Irmela Jeremias
Journal:  Exp Hematol       Date:  2018-09-24       Impact factor: 3.084

4.  Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.

Authors:  Julie Irving; Elizabeth Matheson; Lynne Minto; Helen Blair; Marian Case; Christina Halsey; Isabella Swidenbank; Frida Ponthan; Renate Kirschner-Schwabe; Stefanie Groeneveld-Krentz; Jana Hof; James Allan; Christine Harrison; Josef Vormoor; Arend von Stackelberg; Cornelia Eckert
Journal:  Blood       Date:  2014-09-24       Impact factor: 22.113

Review 5.  The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

Authors:  J Eswaran; P Sinclair; O Heidenreich; J Irving; L J Russell; A Hall; D P Calado; C J Harrison; J Vormoor
Journal:  Leukemia       Date:  2015-05-06       Impact factor: 11.528

6.  Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM.

Authors:  Elizabeth C Matheson; Huw Thomas; Marian Case; Helen Blair; Rosanna K Jackson; Dino Masic; Gareth Veal; Chris Halsey; David R Newell; Josef Vormoor; Julie A E Irving
Journal:  Haematologica       Date:  2019-01-17       Impact factor: 9.941

Review 7.  Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting.

Authors:  Thomas Knight; Julie Anne Elizabeth Irving
Journal:  Front Oncol       Date:  2014-06-24       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.